Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas
Lab / animal
OA: closed
CC0
⤵ 18 in-corpus citations
AI-generated summary
Ectopic pituitary grafts in mice caused hyperprolactinemia, altered progesterone levels, reduced corpora lutea, and increased adenomyosis and mammary carcinomas, particularly in hybrids.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Some endocrinological consequences of grafting hypophyses of mice to sites distant from the hypothalamic-pituitary portal vessels were investigated. Serum PRL levels in recipients rose within 3 weeks to levels seen during pregnancy, resulting in a premature increase in serum progesterone (P) levels. After 7 weeks, luteolytic effects were evident in BALB/c females, and P values had plateaued in the range of those seen in normal adult animals, while in BALB/c X C3H F1 hybrids, this effect was delayed, and P values rose, reaching, in some animals, levels reported during pregnancy. Despite continuing hyperprolactinemia, the fertility of graft-bearing females was reduced only slightly. By the 6th month, lesions of adenomyosis were frequent in uteri of C3H and F1 hybrids, but essentially absent from BALB/c animals. The number of corpora lutea was reduced in all experimental groups, yet serum P values were somewhat elevated in hybrid females and BALB/c animals bearing three grafts. Evidence is presented indicating that PRL enhances the action of P on both the estrogen-stimulating vagina and uterus. Small groups of grafted BALB/c and hybrid females not infected with exogenous mouse mammary tumor virus were allowed to survive until mammary cancers developed or until they reached 18 months of age. The grafts in the hybrids routinely became adenomatous, producing serm PRL levels of 1-21 X 10(3) ng/ml; only one secreted excessive GH. Adenomyosis wained in the aged hybrids, apparently due to declining ovarian function. The majority of the animals developed adenoid cystic mammary cancers that seemed to arise from areas of hyperplasia within dilated ducts rather than from alveolar hyperplasias, as is most frequently the case in mice carrying exogenous mouse mammary tumor virus.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (37)
- Effects of prenatal exposure of mice to "low-dose" diethylstilbestrol and the development of adenomyosis associated with evidence of hyperprolactinemia via openalex
- Mechanisms of development of prolactin-induced adenomyosis in mice via openalex
- The elusive adenomyosis of the uterus. Its historical past and its present state of recognition via openalex
- The induction of adenomyosis in mice by intrauterine pituitary isografts via openalex
- W1575464397 via openalex
- W1587313287 via openalex
- W1968689577 via openalex
- W1980436754 via openalex
- W1983209598 via openalex
- W2011332253 via openalex
- W2016888223 via openalex
- W2024420509 via openalex
- W2029808208 via openalex
- W2033243375 via openalex
- W2036909895 via openalex
- W2042222473 via openalex
- W2043226217 via openalex
- W2048485144 via openalex
- W2050516070 via openalex
- W2072794518 via openalex
- W2081618410 via openalex
- W2085876760 via openalex
- W2091612165 via openalex
- W2101178259 via openalex
- W2108279798 via openalex
- W2123255750 via openalex
- W2127812340 via openalex
- W2146675967 via openalex
- W2169646343 via openalex
- W2313746349 via openalex
- W2409324588 via openalex
- W2410195877 via openalex
- W133565412 via openalex
- W2432851475 via openalex
- W1512336610 via openalex
- W1530521584 via openalex
- W1560409254 via openalex
Cited by (19)
- Increased local prolactin synthesis in the myometrium and endometrium as a probable cause of adenomyosis 2026
- Drug development for adenomyosis based on pathophysiology 2025
- Establishment of a Novel Mouse Model of Adenomyosis Suitable for Longitudinal and Quantitative Analysis and Perinatal Outcome Studies 2022
- Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies 2022
- Establishment of a novel mouse model of adenomyosis suitable for longitudinal and quantitative analysis and perinatal outcome studies 2022
- Unveiling the Pathogenesis of Adenomyosis through Animal Models 2022
- Evaluation Of Mammographic Features In Women With Adenomyosis 2022
- Adenomyosis in mice resulting from mechanically or thermally induced endometrial-myometrial interface disruption and its possible prevention 2020
- Animal Models of Adenomyosis 2020
- Methodological Issues in Preclinical Mouse Efficacy Studies of Adenomyosis 2012
- Use of a murine endometriosis interna model for the characterization of compounds that effectively treat human endometriosis 2011
- Probucol, a hypocholesterolemic agent, prevents the development of uterine adenomyosis induced by pituitary grafting in mice 2004
- Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice 2003
- Increased invasion activity of endometrial stromal cells and elevated expression of matrix metalloproteinase messenger RNA in the uterine tissues of mice with experimentally induced adenomyosis 2001
- Changes in Uterine Microvessels as a Possible Pathogenic Factor in the Development of Adenomyosis Induced by Pituitary Grafting in Mice. 1999
- Increased expression of prolactin receptor mRNA in adenomyotic uterus in mice 1997
- Adenomyosis 1995
- Animal model of uterine adenomyosis: is prolactin a potent inducer of adenomyosis in mice? 1991
- Multiple Endocrine Syndrome in SHN Mice: Mammary Tumors and Uterine Adenomyosis 1989
Source provenance
- europepmc
- last seen: 2026-10-18T09:30:06.152893+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:47:11.652989+00:00
- unpaywall
- last seen: 2026-10-18T06:28:46.490043+00:00
License: CC0
· commercial use OK